Sino Biopharmaceutical Ltd
Sino Biopharmaceutical's GHG Emissions Data Preview
In 2024, Sino Biopharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Sino Biopharmaceutical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Verified Sources Behind Sino Biopharmaceutical’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sino Biopharmaceutical’s data sources below and access millions more through our Disclosure Search.
Insights into Sino Biopharmaceutical's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Sino Biopharmaceutical amounted to 208,220.01 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Sino Biopharmaceutical decreased by 12.97%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
Sino Biopharmaceutical's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Sino Biopharmaceutical's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Sino Biopharmaceutical were 18,238.62 metric tons of CO₂ equivalent (tCO₂e). a
Has Sino Biopharmaceutical reduced its Scope 1 emissions over time?
Since 2021, Sino Biopharmaceutical's Scope 1 emissions have decreased by 16%, reflecting a declining long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2023), Sino Biopharmaceutical's Scope 1 emissions increased by 7%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
What are Sino Biopharmaceutical's Scope 2 emissions?
In 2024, Sino Biopharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 189,981.39 tCO₂e without specifying the calculation method. a
Has Sino Biopharmaceutical reduced its Scope 2 emissions over time?
Since 2021, Sino Biopharmaceutical's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have decreased by 24.97%, reflecting a declining long-term trend in Scope 2 emissions over time. a b
Compared to the previous year (2023), Sino Biopharmaceutical's Scope 2 emissions (Unspecified Calculation Method) fell by 14.5% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption. a
What methodology does Sino Biopharmaceutical use for Scope 2 reporting?
In 2024, Sino Biopharmaceutical reported its Scope 2 emissions using an unspecified methodology. a
Sino Biopharmaceutical's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Sino Biopharmaceutical’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Sino Biopharmaceutical reported Scope 1 greenhouse gas (GHG) emissions of 18,238.62 tCO₂e and total revenues of USD 4,308 millions. This translates into an emissions intensity of 4.23 tCO₂e per millions USD. a
Sino Biopharmaceutical's Scope 1 Emissions Intensity Compared to Peers
How does Sino Biopharmaceutical's GHG emissions intensity compare to its peers?
In 2024, Sino Biopharmaceutical reported a Scope 1 emissions intensity of 4.23 tCO₂e per millions USD. Compared to the peer group median of 3.43 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does Sino Biopharmaceutical rank on GHG emissions intensity within its industry?
In 2024, Sino Biopharmaceutical ranked 16 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Sino Biopharmaceutical is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a